teclistamab,talquetamab,daratumumab
genmab,janssen
['redirectt-1', 'congrat', 'mmsm']
redirectt-1! combo tec&amp;tal! for me the most important abstract from #eha2023. it makes sense to combine 2 bsabs with different targets! 85.7% orr in true emd! exceptional results! #mmsm another congratulations to 
Associate Professor, Dept. of Hematooncology, University Hospital Ostrava;   Head of flow cytometry core, Blood Cancer Research Group, University of Ostrava